title: Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients.
authors.affiliation: Dipartimento di Scienze Cliniche L. Sacco, Università degli Studi di Milano, Ospedale Luigi Sacco, Milan, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Zanichelli
authors.forename: R
authors.initials: R
authors.lastname: Vacchini
authors.forename: M
authors.initials: M
authors.lastname: Badini
authors.forename: V
authors.initials: V
authors.lastname: Penna
authors.forename: M
authors.initials: M
authors.lastname: Cicardi
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000728:Androgens / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D050718:Complement C1 Inhibitor Protein; D003625:Data Collection; D004341:Drug Evaluation; D005260:Female; D056829:Hereditary Angioedema Types I and II / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012008:Recurrence; D059039:Standard of Care; D014148:Tranexamic Acid / Q000627:therapeutic use; D017211:Treatment Failure
chemical_list: D000728:Androgens; D050718:Complement C1 Inhibitor Protein; D014148:Tranexamic Acid